By Counterforce Health Team in Cimzia (certolizumab pegol) —

If Cimzia Isn't Approved by UnitedHealthcare in North Carolina: Formulary Alternatives & Exception Paths

Answer Box: If UnitedHealthcare denies Cimzia (certolizumab pegol) in North Carolina, you have alternatives. First, ask your doctor about preferred TNF inhibitors like Humira biosimilars or Enbrel, which often have better formulary placement. Second, request a step therapy exception if alternatives aren't suitable—UnitedHealthcare must respond within 72 hours. Third, if denied, file an external review through North Carolina's Smart NC program within 120 days for an independent decision. Start by calling UnitedHealthcare member services to verify your plan's formulary tier for Cimzia and alternatives.

Table of Contents

When Alternatives Make Sense

UnitedHealthcare frequently places Cimzia (certolizumab pegol) on higher formulary tiers or requires step therapy through preferred TNF inhibitors first. This is especially common for their Medicare Advantage plans, which have shown higher prior authorization denial rates (12.8%) compared to industry averages.

Considering alternatives makes sense when:

  • Formulary placement: Cimzia is non-formulary or tier 4/5 with high cost-sharing
  • Step therapy requirements: Your plan mandates trying preferred agents first
  • Cost considerations: Alternatives have better coverage or manufacturer support
  • Clinical equivalence: Other TNF inhibitors may work equally well for your condition

However, alternatives may not be appropriate if you have:

  • Previous failures or intolerances to other TNF inhibitors
  • Specific contraindications to preferred agents (e.g., heart failure for certain TNF inhibitors)
  • Pregnancy planning (Cimzia has unique safety profile in pregnancy)
Note: According to research on TNF inhibitor switching, patients who fail one TNF inhibitor have about a 40% response rate to a second TNF inhibitor, but higher success with different mechanism drugs.

Typical TNF Inhibitor Alternatives

UnitedHealthcare's OptumRx formularies typically prefer these alternatives to Cimzia:

First-Line Preferred TNF Inhibitors

Adalimumab (Humira) and Biosimilars

  • Biosimilars available: Hadlima, Cyltezo, Abrilada, Amjevita, Hyrimoz
  • Indications: Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis
  • Administration: Subcutaneous injection every other week
  • Coverage advantage: Multiple biosimilar options drive down costs

Etanercept (Enbrel) and Biosimilars

  • Biosimilars available: Erelzi
  • Indications: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (not Crohn's disease)
  • Administration: Subcutaneous injection weekly or twice weekly
  • Limitation: Not approved for inflammatory bowel disease

Infliximab (Remicade) and Biosimilars

  • Biosimilars available: Inflectra, Renflexis, Ixifi, Avsola
  • Indications: Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis
  • Administration: IV infusion in clinic/hospital setting
  • Coverage note: Often preferred for Crohn's disease

Alternative Mechanism Biologics

If TNF inhibitors fail, UnitedHealthcare may approve:

  • IL-17 inhibitors: Cosentyx (secukinumab), Taltz (ixekizumab)
  • IL-12/23 inhibitors: Stelara (ustekinumab)
  • B-cell depleting agents: Rituxan (rituximab)
  • T-cell costimulation modulators: Orencia (abatacept)

Pros and Cons Overview

Alternative Access Advantages Clinical Considerations Monitoring Requirements
Humira biosimilars Lower cost, broad coverage Proven efficacy, broad indications Standard TNF monitoring
Enbrel Often tier 2-3 Cannot use for Crohn's disease Standard TNF monitoring
Remicade biosimilars Good IBD coverage Requires infusion center More frequent lab monitoring
Non-TNF biologics Exception pathway available Different side effect profile Mechanism-specific monitoring

Testing Requirements

All TNF inhibitors require similar baseline screening:

  • Tuberculosis screening (TST/IGRA, chest X-ray)
  • Hepatitis B and C testing
  • Complete blood count
  • Liver function tests

Exception Strategy

When to Request Step Therapy Exceptions

Request exceptions when:

  1. Previous failures documented: You've tried and failed other TNF inhibitors
  2. Contraindications exist: Medical reasons prevent use of preferred agents
  3. Unique clinical situation: Pregnancy, specific disease patterns, or comorbidities

Evidence That Helps

For Clinicians: Include in your medical necessity letter:

  • Specific prior TNF inhibitor trials with dates, doses, and reasons for discontinuation
  • Clinical guidelines supporting Cimzia use (e.g., ACR guidelines)
  • Laboratory results showing disease activity
  • Documentation of contraindications to preferred agents

For Patients: Gather:

  • Complete medication history
  • Previous authorization approvals/denials
  • Clinical notes from specialist visits
  • Laboratory reports showing disease markers
From our advocates: We've seen success when patients work with their rheumatologist or gastroenterologist to document specific intolerances to preferred TNF inhibitors. One composite case involved a patient whose Humira caused injection site reactions severe enough to affect daily activities—this specific documentation helped secure Cimzia approval on exception.

Switching Logistics

Coordination with Your Provider

  1. Discuss timing: No washout period needed when switching between TNF inhibitors
  2. Update monitoring: Schedule labs at 12-16 weeks after starting new therapy
  3. Document response: Track disease activity scores for future appeals if needed

Pharmacy Coordination

  • Specialty pharmacy: Most biologics require specialty pharmacy dispensing
  • Insurance verification: Confirm new drug coverage before discontinuing current therapy
  • Patient assistance: Apply for manufacturer copay programs for new medication

Transition Timeline

Week Action Responsibility
0 Submit PA for alternative Prescriber
1-2 PA decision received Monitor status
2-3 Start new therapy if approved Patient/clinic
12-16 Assess clinical response Prescriber

Re-trying for Cimzia Later

What to Document During Alternative Trial

Keep detailed records of:

  • Efficacy: Disease activity scores, symptom diaries, functional assessments
  • Side effects: Any adverse reactions, severity, impact on quality of life
  • Adherence: Missed doses, reasons for non-compliance
  • Laboratory changes: Monitoring results, any concerning trends

When to Reapproach Cimzia

Consider requesting Cimzia again if:

  • Alternative therapy fails after adequate trial (typically 3-6 months)
  • New contraindications develop to current therapy
  • Clinical guidelines change to support Cimzia use
  • Your insurance formulary updates

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform can help identify the specific denial basis and draft point-by-point rebuttals aligned to your plan's own rules, incorporating the right clinical evidence and procedural requirements for UnitedHealthcare appeals in North Carolina.

Appeals Playbook for North Carolina

Internal Appeals with UnitedHealthcare

Level 1 Internal Appeal

  • Deadline: 180 days from denial notice
  • Timeline: 15-30 days standard, 72 hours expedited
  • How to file: UnitedHealthcare member portal or mail to address on denial letter
  • Required documents: Original denial letter, medical records, physician letter

Peer-to-Peer Review

  • When: Before or during internal appeal
  • Timeline: Must be requested within 30 days of denial
  • Process: Your doctor speaks directly with UnitedHealthcare medical director
  • Success rate: Higher overturn rates with proper clinical documentation

External Review Through Smart NC

If UnitedHealthcare upholds their denial, you can request external review through North Carolina's Smart NC program:

Eligibility

  • State-regulated plan (not self-funded employer plans unless they opted in)
  • Denial based on medical necessity or experimental treatment determination
  • Exhausted internal appeals (or qualify for expedited review)

Timeline

  • Standard review: 45 days for decision
  • Expedited review: 72 hours for urgent medical conditions
  • Filing deadline: 120 days from final internal denial

How to File

  1. Call Smart NC at 1-855-408-1212 for free assistance
  2. Submit external review request form (available on NCDOI website)
  3. Include all relevant medical records and documentation
  4. Pay $25 fee (waived for financial hardship or Medicaid recipients)

Success Factors According to Smart NC guidance, specialty drug appeals have a "high success rate" when complete documentation is provided.

Tip: You can submit additional medical records within 7 days of filing your external review request. Use this time to gather any missing clinical documentation.

FAQ

How long does UnitedHealthcare prior authorization take in North Carolina? Standard prior authorization decisions are made within 15 days. Urgent requests must be decided within 72 hours. You can track status through the UnitedHealthcare member portal.

What if Cimzia is non-formulary on my plan? Non-formulary drugs can still be covered through medical exception requests. Your doctor must demonstrate medical necessity and why formulary alternatives aren't appropriate.

Can I request an expedited appeal if my condition is worsening? Yes. If delay would seriously jeopardize your health or ability to regain function, request expedited internal appeal (72 hours) and potentially expedited external review through Smart NC.

Does step therapy apply if I failed TNF inhibitors outside North Carolina? Previous treatment failures should be documented regardless of where they occurred. UnitedHealthcare should honor documented failures from other states with proper medical records.

Are there cost assistance programs for alternative TNF inhibitors? Most manufacturers offer patient assistance programs. Humira biosimilars, Enbrel, and Remicade biosimilars all have copay reduction programs for eligible patients.

What's the difference between medical necessity and step therapy exceptions? Medical necessity exceptions argue that the drug is clinically appropriate for your condition. Step therapy exceptions argue that you should skip preferred alternatives due to contraindications or previous failures.

When navigating UnitedHealthcare denials in North Carolina, remember that you have multiple pathways to access needed medications. Whether through formulary alternatives, exception requests, or the state's external review process, persistence and proper documentation often lead to coverage approval. Counterforce Health and Smart NC provide valuable support throughout this process.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your insurance company and consult healthcare providers for medical decisions.

Sources & Further Reading:

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.